Mumps risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 12: | Line 12: | ||
*The risk of exposure to mumps among travelers can be high in most countries of the world, especially for travelers who are older than 12 months and who do not have evidence of mumps immunity. | *The risk of exposure to mumps among travelers can be high in most countries of the world, especially for travelers who are older than 12 months and who do not have evidence of mumps immunity. | ||
*Working or living in close proximity to an individual infected with Rubulavirus (e.g. classrooms, college dormatories). | |||
*[[Immunodeficiency|Immunodeficieny states]] | *[[Immunodeficiency|Immunodeficieny states]] |
Revision as of 16:07, 10 March 2016
Mumps Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mumps risk factors On the Web |
American Roentgen Ray Society Images of Mumps risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]; Nate Michalak, B.A.
Overview
Risk Factors
- Unvaccinated individuals who do not have evidence of immunity.
- Acceptable presumptive evidence of immunity to mumps includes: documented administration of two doses of live mumps virus vaccine at least 28 days apart, on or after the first birthday; laboratory evidence of immunity; birth before 1957; or documentation of physician-diagnosed mumps.
- Individuals with only 1 dose of the MMR or MMRV vaccine are at higher risk than those with 2 doses.
- The risk of exposure to mumps among travelers can be high in most countries of the world, especially for travelers who are older than 12 months and who do not have evidence of mumps immunity.
- Working or living in close proximity to an individual infected with Rubulavirus (e.g. classrooms, college dormatories).